Simultaneous Blockade of IL-4 and IL-13 Signaling With Dupilumab Attenuates Type 2 Inflammation and Airway Remodeling in a Mouse Model of Severe Airway Disease
Asrat S, Scott G, Srivatsan S, Ben L, Birchard D, Lim W, Nagashima K, Le Floc'h A, Allinne J, Murphy A, Sleeman M, Orengo J. Simultaneous Blockade of IL-4 and IL-13 Signaling With Dupilumab Attenuates Type 2 Inflammation and Airway Remodeling in a Mouse Model of Severe Airway Disease. 2024, a5387-a5387. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5387.Peer-Reviewed Original Research